Prolonged exposure to (R)-bicalutamide generates a LNCaP subclone with alteration of mitochondrial genome

scientific article published on 25 October 2013

Prolonged exposure to (R)-bicalutamide generates a LNCaP subclone with alteration of mitochondrial genome is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.MCE.2013.10.022
P698PubMed publication ID24397920
P5875ResearchGate publication ID259125143

P50authorAnna TeseiQ38641349
Gabriella CastoriaQ55396373
Marzia Di DonatoQ57013006
Chiara ArientiQ57079239
Sara PignattaQ57231219
Ugo De GiorgiQ88923334
P2093author name stringWainer Zoli
Rosella Silvestrini
Valentina Casadio
Mirella Falconi
Elisa Gabucci
P2860cites workIntegrative genomic profiling of human prostate cancerQ29619905
P433issue1
P921main subject(R)-bicalutamideQ63390492
P304page(s)314-324
P577publication date2013-10-25
P1433published inMolecular and Cellular EndocrinologyQ1573600
P1476titleProlonged exposure to (R)-bicalutamide generates a LNCaP subclone with alteration of mitochondrial genome
P478volume382

Reverse relations

cites work (P2860)
Q41161118(18)F-Fluorocholine PET/CT for early response assessment in patients with metastatic castration-resistant prostate cancer treated with enzalutamide.
Q49497675Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
Q35742477Mechanistic rationale for MCL1 inhibition during androgen deprivation therapy
Q35823109MicroRNA Library-Based Functional Screening Identified Androgen-Sensitive miR-216a as a Player in Bicalutamide Resistance in Prostate Cancer
Q37109776Preclinical evidence of multiple mechanisms underlying trastuzumab resistance in gastric cancer.
Q52771926lncRNA HOXD-AS1 Regulates Proliferation and Chemo-Resistance of Castration-Resistant Prostate Cancer via Recruiting WDR5.

Search more.